Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: Jun 25, 2026, 4:00 PM EDT
1.121
-0.009 (-0.76%)
After-hours: Jun 25, 2026, 7:32 PM EDT
Pliant Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
49
Market Cap
69.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.58M | -8.11M | -83.69% |
| Dec 31, 2022 | 9.69M | 2.11M | 27.91% |
| Dec 31, 2021 | 7.57M | -34.25M | -81.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPLRX News
- 5 weeks ago - Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 5 weeks ago - Pliant Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Pliant Therapeutics reports Q1 EPS (32c), consensus (36c) - TheFly
- 6 weeks ago - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Pliant Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Pliant Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Pliant Therapeutics doses first participant in FORTIFY expansion trial - TheFly